Runxuan Chu

721 total citations
18 papers, 541 citations indexed

About

Runxuan Chu is a scholar working on Biomedical Engineering, Biomaterials and Materials Chemistry. According to data from OpenAlex, Runxuan Chu has authored 18 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 6 papers in Biomaterials and 6 papers in Materials Chemistry. Recurrent topics in Runxuan Chu's work include Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Runxuan Chu is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Runxuan Chu collaborates with scholars based in China and Hong Kong. Runxuan Chu's co-authors include Jianglong Kong, Yi Wang, Weiyue Feng, Bing Wang, Meiru Mao, Xiaohan Ge, Hanqing Chen, Meng Wang, Lingna Zheng and Zhifang Chai and has published in prestigious journals such as Advanced Materials, ACS Nano and Advanced Functional Materials.

In The Last Decade

Runxuan Chu

18 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Runxuan Chu China 11 232 192 189 116 32 18 541
Artur Y. Prilepskii Russia 16 276 1.2× 205 1.1× 200 1.1× 108 0.9× 35 1.1× 30 653
Meiru Mao China 13 245 1.1× 146 0.8× 161 0.9× 108 0.9× 17 0.5× 22 565
Jianglong Kong China 18 361 1.6× 271 1.4× 196 1.0× 171 1.5× 59 1.8× 41 828
Zhijie Sun China 15 183 0.8× 76 0.4× 298 1.6× 111 1.0× 35 1.1× 35 673
Chalermchai Pilapong Thailand 14 169 0.7× 256 1.3× 126 0.7× 146 1.3× 69 2.2× 50 648
Farhad Bani Iran 13 221 1.0× 166 0.9× 112 0.6× 152 1.3× 16 0.5× 35 578
Svetlana Romanova United States 12 132 0.6× 173 0.9× 119 0.6× 132 1.1× 23 0.7× 19 570
Danfeng Chang China 9 221 1.0× 188 1.0× 277 1.5× 189 1.6× 26 0.8× 11 662
Vasanthan Ravichandran India 15 306 1.3× 144 0.8× 121 0.6× 160 1.4× 37 1.2× 21 653
Surya P. Singh India 9 175 0.8× 223 1.2× 155 0.8× 139 1.2× 20 0.6× 16 652

Countries citing papers authored by Runxuan Chu

Since Specialization
Citations

This map shows the geographic impact of Runxuan Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runxuan Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runxuan Chu more than expected).

Fields of papers citing papers by Runxuan Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runxuan Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runxuan Chu. The network helps show where Runxuan Chu may publish in the future.

Co-authorship network of co-authors of Runxuan Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Runxuan Chu. A scholar is included among the top collaborators of Runxuan Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runxuan Chu. Runxuan Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chu, Runxuan, Jianglong Kong, Qiang Gao, et al.. (2025). Ether bond-modified lipid nanoparticles for enhancing the treatment effect of hepatic fibrosis. International Journal of Pharmaceutics. 671. 125192–125192. 1 indexed citations
2.
Kong, Jianglong, Runxuan Chu, Meiru Mao, et al.. (2025). A 3-in-1 wearable and implantable biopatch for integrated in-body energy harvesting, sensing, and self-powered diabetic wound treatments. Nano Energy. 136. 110743–110743. 3 indexed citations
3.
Kong, Jianglong, Siyuan Ma, & Runxuan Chu. (2025). Plant protein–based active and smart food packaging: applications and perspectives. Food Hydrocolloids. 172. 111864–111864. 1 indexed citations
4.
Chu, Runxuan, et al.. (2024). Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders. Journal of Materials Chemistry B. 12(20). 4759–4784. 19 indexed citations
5.
Pan, Ting, Runxuan Chu, Shumin Zheng, et al.. (2024). Microfluidic-Enabled Assembly of Multicomponent Artificial Organelle for Synergistic Tumor Starvation Therapy. ACS Applied Materials & Interfaces. 16(31). 40667–40681. 3 indexed citations
6.
Kong, Jianglong, Runxuan Chu, Hongrui Yu, et al.. (2024). Reactive oxygen species-responsive nanotherapy for the prevention and treatment of cerebral ischemia–reperfusion injury. Chemical Engineering Journal. 494. 153023–153023. 7 indexed citations
8.
Kong, Jianglong, Sihan Ma, Runxuan Chu, et al.. (2023). Photothermal and Photocatalytic Glycol Chitosan and Polydopamine‐Grafted Oxygen Vacancy Bismuth Oxyiodide (BiO1‐xI) Nanoparticles for the Diagnosis and Targeted Therapy of Diabetic Wounds. Advanced Materials. 36(11). e2307695–e2307695. 54 indexed citations
9.
Kong, Jianglong, Xiaohan Ge, Yuting Sun, et al.. (2022). Multi-functional pH-sensitive active and intelligent packaging based on highly cross-linked zein for the monitoring of pork freshness. Food Chemistry. 404(Pt B). 134754–134754. 82 indexed citations
10.
Kong, Jianglong, Runxuan Chu, & Yi Wang. (2022). Neuroprotective Treatments for Ischemic Stroke: Opportunities for Nanotechnology. Advanced Functional Materials. 32(52). 30 indexed citations
11.
Chen, Hanqing, Shuang Zhou, Lingna Zheng, et al.. (2021). Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload. Nanotoxicology. 15(6). 761–778. 22 indexed citations
12.
Yu, Hongyang, Runxuan Chu, Xue Li, et al.. (2021). Interaction of Humic Acid with Graphene Oxide: Relation to Antibacterial Activities Against Escherichia coli. Journal of Nanoscience and Nanotechnology. 21(3). 1430–1438. 2 indexed citations
13.
Li, Xue, Hongyang Yu, Bing Wang, et al.. (2021). Multiscale Synchrotron-Based Imaging Analysis for the Transfer of PEGylated Gold Nanoparticles In Vivo. ACS Biomaterials Science & Engineering. 7(4). 1462–1474. 5 indexed citations
14.
Xue, Li, Bing Wang, Shuang Zhou, et al.. (2020). Surface chemistry governs the sub-organ transfer, clearance and toxicity of functional gold nanoparticles in the liver and kidney. Journal of Nanobiotechnology. 18(1). 45–45. 102 indexed citations
15.
Wang, Bing, Xue Li, Shanshan Liang, et al.. (2020). Adsorption and oxidation of SO2 on the surface of TiO2 nanoparticles: the role of terminal hydroxyl and oxygen vacancy–Ti3+ states. Physical Chemistry Chemical Physics. 22(18). 9943–9953. 30 indexed citations
16.
Liang, Shanshan, Bing Wang, Xue Li, et al.. (2020). In vivo pharmacokinetics, transfer and clearance study of graphene oxide by La/Ce dual elemental labelling method. NanoImpact. 17. 100213–100213. 16 indexed citations
17.
18.
Baimanov, Didar, Junguang Wu, Runxuan Chu, et al.. (2020). Immunological Responses Induced by Blood Protein Coronas on Two-Dimensional MoS2 Nanosheets. ACS Nano. 14(5). 5529–5542. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026